Suppr超能文献

肾移植受者的人外周血CD8 + CD28 - T细胞不表达FOXP3蛋白。

Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein.

作者信息

Korecka-Polak A, Duszota A, Wierzbicki P, Niemczyk M, Bocian K, Kłosowska D, Paczek L, Górski A, Korczak-Kowalska G

机构信息

Department of Immunology, Faculty of Biology, University of Warsaw, Poland.

出版信息

Transplant Proc. 2011 Oct;43(8):2917-21. doi: 10.1016/j.transproceed.2011.08.016.

Abstract

INTRODUCTION

In recent studies, the FOXP3 molecule has been suggested to be a marker of a suppressor subset of human CD8+ CD28- T cells based on correlations between the level of its mRNA and allograft function. Because this transcriptional factor produces a protein, we suggest that these correlations should focus on the FOXP3 protein. The aim of our study was to evaluate whether FOXP3 protein was present in cells of the CD8+ CD28- population in the peripheral blood of renal allograft recipients and whether the level of CD8+ CD28- FOXP3+ cells correlated with allograft function.

METHODS

The study was performed on 30 renal allograft recipients with uneventful stable courses (n=18) or biopsy-proven chronic rejection (n=12). The immunosuppression was based on cyclosporine (n=12) or rapamycin (n=9). Peripheral blood mononuclear cells isolated from recipient blood samples were labeled with anti-CD8 and anti-CD28 MAbs conjugated with fluorochromes. After incubation, washing, and labeling using a PE anti-human FOXP3 Kit, we determined the percentage of cells by flow cytometry.

RESULTS

FOXP3 protein expression was not observed either in the CD8+ CD28- population, or the whole populations of CD8+ or CD28- cells among patient groups.

CONCLUSIONS

The expression of FOXP3 protein in CD8+ CD28- cells seems to be of a questionable value as a diagnostic tool for allograft function, it is probably not a marker for the CD8+ CD28- T cell subset.

摘要

引言

在最近的研究中,基于FOXP3分子mRNA水平与同种异体移植功能之间的相关性,有人提出FOXP3分子是人类CD8+ CD28-T细胞抑制亚群的标志物。由于这种转录因子会产生一种蛋白质,我们认为这些相关性应聚焦于FOXP3蛋白。我们研究的目的是评估肾移植受者外周血中CD8+ CD28-细胞群体中是否存在FOXP3蛋白,以及CD8+ CD28- FOXP3+细胞水平是否与同种异体移植功能相关。

方法

该研究对30例肾移植受者进行,其中18例病情平稳,12例经活检证实为慢性排斥反应。免疫抑制方案基于环孢素(12例)或雷帕霉素(9例)。从受者血样中分离出的外周血单个核细胞用与荧光染料偶联的抗CD8和抗CD28单克隆抗体进行标记。孵育、洗涤后,使用PE抗人FOXP3试剂盒进行标记,然后通过流式细胞术测定细胞百分比。

结果

在患者组的CD8+ CD28-细胞群体以及CD8+或CD28-细胞的整个群体中均未观察到FOXP3蛋白表达。

结论

FOXP3蛋白在CD8+ CD28-细胞中的表达作为同种异体移植功能的诊断工具,其价值似乎值得怀疑,它可能不是CD8+ CD28-T细胞亚群的标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验